One method involves suppressing the occurrence and development of DCM by lowering the blood glucose concentration and insulin resistance, using hypoglycemic drugs such as sulfonylurea, α-carbosidase inhibitors, biguanides, and insulin (Deedwania and Acharya, 2019). The gene discussed is INS; the disease is familial dilated cardiomyopathy.